How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?

被引：0
|
作者：
Matsuoka, T. [1 ,2 ,3 ]
Araki, M. [4 ]
Yamaguchi, H. [1 ]
Sato, W. [1 ]
Miyamoto, K. [5 ]
Kusunoki, S. [5 ]
Gold, R. [6 ]
Yamamura, T. [1 ,4 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Natl Inst Neurosci, Dept Immunol,Natl Ctr Neurol & Psychiat, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo, Japan
[3] Natl Ctr Neurol & Psychiat, Tokyo Metropolitan Inst Neurosci, Child Brain Project, Tokyo, Japan
[4] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Multiple Sclerosis Ctr, Tokyo, Japan
[5] Kindai Univ, Dept Neurol, Fac Med, Osaka, Japan
[6] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1755
引用
收藏
页码：1000 / 1001
页数：2
相关论文
共 50 条
  • [1] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab for the treatment of neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 947 - 947
  • [2] Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica
    Araki, Manabu
    Matsuoka, Takako
    Aranami, Toshimasa
    Nakamura, Masakazu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Yamamura, Takashi
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 911 - 912
  • [3] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab in three patients with neuromyelitis optica
    Araki, M.
    Aranami, T.
    Matsuoka, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 417 - 417
  • [4] Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
    Araki, Manabu
    Aranami, Toshimasa
    Matsuoka, Takako
    Nakamura, Masakazu
    Miyake, Sachiko
    Yamamura, Takashi
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 827 - 831
  • [5] Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
    Araki, Manabu
    Matsuoka, Takako
    Miyamoto, Katsuichi
    Kusunoki, Susumu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Aranami, Toshimasa
    Yamamura, Takashi
    NEUROLOGY, 2014, 82 (15) : 1302 - 1306
  • [6] Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 326 - 327
  • [7] Immunomodulatory effect of anti-IL6 receptor monoclonal antibody tocilizumab in patients with neuromyelitis optica
    Matsuoka, T.
    Chiba, A.
    Aranami, T.
    Araki, M.
    Nakamura, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 463 - 464
  • [8] Tocilizumab - A humanized anti-IL-6 receptor monoclonal antibody for the treatment of rheumatoid arthritis
    Schlesselman, Lauren S.
    Hussey, Aaron P.
    FORMULARY, 2008, 43 (08) : 272 - 279
  • [9] Anti-IL-6 receptor antibody does not ameliorate radiation pneumonia in mice
    Ogata, Toshiyuki
    Yamazaki, Hideya
    Teshima, Teruki
    Tsuchiya, Takahiro
    Nishimoto, Norihiro
    Matsuura, Nariaki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (02) : 273 - 276
  • [10] Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis
    El-Zayadi, Ahmed A.
    Mohamed, Sara A.
    Arafa, Mohammad
    Mohammed, Shereen M.
    Zayed, Abdelhady
    Abdelhafez, Mohamed S.
    Badawy, Ahmed M.
    IMMUNOLOGIC RESEARCH, 2020, 68 (06) : 389 - 397
12345